Implications of the BIA‐102474‐101 study for review of first‐into‐human clinical trials

Over the past 10 years, thousands of first‐into‐human (FIH) clinical trials have been performed in Europe, with few severe adverse events (SAEs). Each has received detailed prior safety review at both the local clinical research facility and at national drug regulatory authority level. The recent…